InvestorsHub Logo
Followers 59
Posts 2267
Boards Moderated 0
Alias Born 02/13/2016

Re: antihama post# 2094

Tuesday, 03/20/2018 10:01:11 AM

Tuesday, March 20, 2018 10:01:11 AM

Post# of 3283
Sorry, but I disagree.

The primary was:"Duration of severe neutropenia (DSN) in Cycle 1 "

That is tested here for both non-inferiority and superiority. It is one test. Multiplicity is not a concern.

They said the trial demonstrated NI. Had the results of the statistical test demonstrated superiority I believe that would have been disclosed.

Superiority is not a "secondary" endpoint.